Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinolysin ointment versus ozone oil for deep second-degree burns
IRCT20250524065868N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2025
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of plasmin in burn injury (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Burn treatment and Wound color analysis. Started Aug 2025; status: completed.
02
Drugs
plasmin
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20250524065868N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250524065868N1.